Sessa Capital (Master), L.P. - Director at SAB Biotherapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Company
Role
Director
Stock Symbol
SABS, SABSW on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Sessa Capital (Master), L.P. since 4/23/2024

Holdings reported by Sessa Capital (Master), L.P. for SAB Biotherapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Series A-2 Convertible Preferred Stock 28.4K $28.4M $1,000.00 Nov 24, 2023 Direct Common Stock
Common Stock 4.58M $4.03M $0.88 Nov 24, 2023 Direct
Tranche C Warrants 52.1K Nov 10, 2023 Direct Series A-3 Convertible Preferred Stock
Tranche B Warrants 20.8K Nov 10, 2023 Direct Series A-3 Convertible Preferred Stock
Series A-1 Convertible Preferred Stock 0 $1,000.00 Nov 24, 2023 Direct Common Stock or Series A-2 Convertible Preferred Stock
Tranche A Warrants 0 Nov 13, 2023 Direct Series A-1 or Series A-3 Convertible Preferred Stock

Transactions reported by Sessa Capital (Master), L.P. for SAB Biotherapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.